Opens in a new tab

Dr. Zheng Jinping

Chinese name: 郑劲平
Chief Physician, Professor, Doctoral Supervisor . Respiratory Medicine & Pulmonary Function Testing
Dr. Zheng Jinping is Professor of Respiratory Medicine and Deputy Director of the Guangzhou Institute of Respiratory Health at the First Affiliated Hospital of Guangzhou Medical University. An authority on pulmonary function testing, he leads national efforts to standardise spirometry, serves on the GOLD Science Committee and has led major studies on COPD diagnosis, spirometry and early-stage treatment.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+ years
Respiratory medicine and pulmonary function practice
60+ papers
First/corresponding-author papers
30+ papers
SCI-indexed publications

  • The Physician

About Dr. Zheng Jinping

Dr. Zheng Jinping is Professor of Respiratory Medicine at the First Affiliated Hospital of Guangzhou Medical University and Deputy Director of the Guangzhou Institute of Respiratory Health, the National Clinical Research Centre for Respiratory Disease and the State Key Laboratory of Respiratory Disease. He has spent more than three decades on pulmonary function testing and chronic airway disease, leading nationwide programmes to standardise spirometry and training clinicians across China. He is a member of the GOLD Science Committee, has edited several books on pulmonary function, and has led national research projects on COPD diagnosis and treatment.
1、Professor of Respiratory Medicine and Deputy Director of the Guangzhou Institute of Respiratory Health
2、Deputy Director of the National Clinical Research Centre for Respiratory Disease
3、Deputy Director of the State Key Laboratory of Respiratory Disease
4、Vice President of Nanshan College of Guangzhou Medical University
5、Member of the GOLD Science Committee
6、Leader of national standardised pulmonary function testing training programmes in China
7、Editor of multiple books on pulmonary function testing

Dr. Zheng Jinping ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Pulmonary function testing and diagnosis

He performs and interprets spirometry, bronchodilator and bronchial challenge tests, diffusion and impulse oscillometry, applying quality control and standardised protocols to diagnose asthma, COPD and other respiratory diseases accurately and to monitor treatment response and disease progression over the long term.

Chronic obstructive pulmonary disease

He diagnoses and treats chronic obstructive pulmonary disease with inhaled therapy and individualised management, using lung function and symptom assessment to detect the disease early, slow lung function decline and reduce exacerbations in patients at different stages, including mild and early disease.

Asthma and chronic airway disease

He manages asthma, chronic cough and airway hyperresponsiveness with evidence-based inhaled treatment and objective monitoring of lung function and airway inflammation, tailoring therapy to control symptoms, reduce attacks and preserve breathing capacity in children, adults and older patients and improve their quality of life.

More：spirometry——standardisation and training; bronchodilator response——assessment; COPD screening——early detection; respiratory physiology——research; impulse oscillometry——diagnosis

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Tiotropium in early-stage chronic obstructive pulmonary disease (Tie-COPD trial)
A landmark randomized, double-blind, placebo-controlled trial showing that early treatment with tiotropium in patients with mild-to-moderate chronic obstructive pulmonary disease significantly slows the decline of lung function, informing early pharmacologic intervention for COPD patients diagnosed with early-stage disease in China.
2. Tie-COPD study protocol: tiotropium in early COPD
A published protocol of a multicenter randomized controlled trial designed to test whether tiotropium delays the decline of forced expiratory volume in one second in patients with early-stage chronic obstructive pulmonary disease in primary and secondary hospitals, supporting evidence-based early COPD management in China.
3. Tiotropium Respimat 5 microgram in Chinese patients with COPD
A randomized clinical trial evaluating the efficacy and safety of once-daily tiotropium Respimat five micrograms in Chinese patients with moderate-to-severe chronic obstructive pulmonary disease, demonstrating improved lung function and symptom control compared with placebo treatment in this Chinese population group.
4. Spirometry reference values: GLI-2012 versus GIRH-2017 in Chinese adults
A comparative study assessing whether the Global Lung Function Initiative equations or the newer Chinese reference equations better interpret spirometry results in Chinese adults, improving the accuracy of pulmonary function testing and COPD diagnosis in routine clinical practice and follow-up.
5. Peak expiratory flow reference values for healthy Chinese children
A multicenter study establishing reference values and predictive equations for peak expiratory flow in healthy Chinese children, providing a practical, reliable and widely used tool for routine lung function assessment and asthma monitoring in pediatric respiratory care across the country in China.
6. Tie-COPD randomized controlled trial registry
A registered multicenter, randomized controlled trial comparing early tiotropium treatment with placebo in patients with early-stage chronic obstructive pulmonary disease, designed to determine whether early bronchodilation preserves lung function in Chinese patients, one of the earliest large COPD trials conducted across China.
  • Affiliated Hospital

Where Dr. Zheng Jinping practices

Guangzhou

The First Affiliated Hospital of Guangzhou Medical University

Chinese name: 广州医科大学附属第一医院
Guangzhou Medical University First Affiliated Hospital, founded in 1903 and led by respiratory scientist Academician Zhong Nanshan, hosts the National Respiratory Medical Center and a national key laboratory, offering 13 national key specialties across 2,850 beds as one of China's leading respiratory-care institutions.
Since 1903
123 years of care
2,850
Licensed beds
15
National-level platforms
Host institution
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zheng Jinping?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zheng Jinping.